US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 3.719
  • +0.119+3.31%
Trading Dec 12 13:26 ET
158.10MMarket Cap-1.87P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
-96.45%1.07M
822.93%52.4M
-61.21%51.13M
-28.31%13.05M
-98.08%2.16M
4,354.93%30.25M
1,291.67%5.68M
1,634.61%131.83M
164.62%18.2M
Operating revenue
--0
-96.45%1.07M
822.93%52.4M
-61.21%51.13M
-28.31%13.05M
-98.08%2.16M
4,354.93%30.25M
1,291.67%5.68M
1,634.61%131.83M
164.62%18.2M
Cost of revenue
Gross profit
Operating expense
-14.13%34.85M
-9.68%38.39M
3.05%41.59M
10.37%167.36M
16.08%43.91M
3.66%40.58M
7.85%42.51M
14.54%40.36M
30.42%151.63M
6.23%37.83M
Selling and administrative expenses
-18.10%6.44M
-4.61%8.32M
1.04%8.62M
3.70%33.76M
8.93%8.65M
-0.46%7.87M
9.84%8.72M
-2.85%8.53M
24.21%32.56M
3.93%7.94M
-General and administrative expense
-18.10%6.44M
-4.61%8.32M
1.04%8.62M
3.70%33.76M
8.93%8.65M
-0.46%7.87M
9.84%8.72M
-2.85%8.53M
24.21%32.56M
3.93%7.94M
Research and development costs
-13.17%28.4M
-10.99%30.08M
3.58%32.97M
12.20%133.59M
17.98%35.27M
4.70%32.71M
7.35%33.79M
20.30%31.83M
32.23%119.07M
6.86%29.89M
Operating profit
9.30%-34.85M
-204.45%-37.32M
131.19%10.82M
-487.11%-116.22M
-57.23%-30.87M
-152.34%-38.42M
68.35%-12.26M
0.42%-34.68M
81.78%-19.8M
31.68%-19.63M
Net non-operating interest income expense
-24.15%2.51M
-17.05%2.89M
-13.39%2.97M
136.80%13.33M
5.97%3.11M
63.39%3.31M
541.36%3.49M
2,556.59%3.43M
2,074.13%5.63M
2,718.27%2.93M
Non-operating interest income
-24.15%2.51M
-17.05%2.89M
-13.39%2.97M
136.80%13.33M
5.97%3.11M
63.39%3.31M
541.36%3.49M
2,556.59%3.43M
2,074.13%5.63M
2,718.27%2.93M
Other net income (expense)
-2,105.56%-1.59M
65.67%-23K
109.86%7K
-209.06%-289K
-211.27%-79K
-180.90%-72K
-151.54%-67K
-184.00%-71K
243.24%265K
198.61%71K
Gain on sale of security
52.50%-19K
114.63%6K
155.36%31K
-155.19%-170K
-156.90%-33K
-131.75%-40K
-129.08%-41K
-229.41%-56K
313.89%308K
211.54%58K
Special income (charges)
---1.53M
----
----
----
----
--0
----
----
----
----
-Less：Restructuring and merger&acquisition
--1.53M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-31.25%-42K
-11.54%-29K
-60.00%-24K
-176.74%-119K
-453.85%-46K
13.51%-32K
-136.36%-26K
-87.50%-15K
-4.88%-43K
165.00%13K
Income before tax
3.57%-33.92M
-289.86%-34.45M
144.03%13.79M
-642.29%-103.18M
-67.41%-27.84M
-146.58%-35.18M
76.78%-8.84M
9.79%-31.33M
87.20%-13.9M
42.06%-16.63M
Income tax
102.98%485K
-89.52%326K
-82.61%629K
-161.95%-9.38M
-98.74%190K
-30,283.33%-16.3M
9,324.24%3.11M
11,200.00%3.62M
1,002.68%15.15M
3,747.57%15.03M
Net income
-82.24%-34.41M
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
Net income continuous Operations
-82.24%-34.41M
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
Minority interest income
Net income attributable to the parent company
-82.24%-34.41M
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-82.24%-34.41M
-191.09%-34.77M
137.67%13.16M
-222.91%-93.8M
11.46%-28.03M
-125.02%-18.88M
68.64%-11.95M
-0.53%-34.94M
72.83%-29.05M
-11.91%-31.66M
Basic earnings per share
-80.00%-0.81
-192.86%-0.82
137.35%0.31
-223.19%-2.23
10.67%-0.67
-125.00%-0.45
69.23%-0.28
0.00%-0.83
75.62%-0.69
-7.14%-0.75
Diluted earnings per share
-80.00%-0.81
-192.86%-0.82
136.14%0.3
-223.19%-2.23
10.67%-0.67
-126.32%-0.45
69.23%-0.28
0.00%-0.83
75.62%-0.69
-7.14%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0-96.45%1.07M822.93%52.4M-61.21%51.13M-28.31%13.05M-98.08%2.16M4,354.93%30.25M1,291.67%5.68M1,634.61%131.83M164.62%18.2M
Operating revenue --0-96.45%1.07M822.93%52.4M-61.21%51.13M-28.31%13.05M-98.08%2.16M4,354.93%30.25M1,291.67%5.68M1,634.61%131.83M164.62%18.2M
Cost of revenue
Gross profit
Operating expense -14.13%34.85M-9.68%38.39M3.05%41.59M10.37%167.36M16.08%43.91M3.66%40.58M7.85%42.51M14.54%40.36M30.42%151.63M6.23%37.83M
Selling and administrative expenses -18.10%6.44M-4.61%8.32M1.04%8.62M3.70%33.76M8.93%8.65M-0.46%7.87M9.84%8.72M-2.85%8.53M24.21%32.56M3.93%7.94M
-General and administrative expense -18.10%6.44M-4.61%8.32M1.04%8.62M3.70%33.76M8.93%8.65M-0.46%7.87M9.84%8.72M-2.85%8.53M24.21%32.56M3.93%7.94M
Research and development costs -13.17%28.4M-10.99%30.08M3.58%32.97M12.20%133.59M17.98%35.27M4.70%32.71M7.35%33.79M20.30%31.83M32.23%119.07M6.86%29.89M
Operating profit 9.30%-34.85M-204.45%-37.32M131.19%10.82M-487.11%-116.22M-57.23%-30.87M-152.34%-38.42M68.35%-12.26M0.42%-34.68M81.78%-19.8M31.68%-19.63M
Net non-operating interest income expense -24.15%2.51M-17.05%2.89M-13.39%2.97M136.80%13.33M5.97%3.11M63.39%3.31M541.36%3.49M2,556.59%3.43M2,074.13%5.63M2,718.27%2.93M
Non-operating interest income -24.15%2.51M-17.05%2.89M-13.39%2.97M136.80%13.33M5.97%3.11M63.39%3.31M541.36%3.49M2,556.59%3.43M2,074.13%5.63M2,718.27%2.93M
Other net income (expense) -2,105.56%-1.59M65.67%-23K109.86%7K-209.06%-289K-211.27%-79K-180.90%-72K-151.54%-67K-184.00%-71K243.24%265K198.61%71K
Gain on sale of security 52.50%-19K114.63%6K155.36%31K-155.19%-170K-156.90%-33K-131.75%-40K-129.08%-41K-229.41%-56K313.89%308K211.54%58K
Special income (charges) ---1.53M------------------0----------------
-Less：Restructuring and merger&acquisition --1.53M------------------0----------------
Other non- operating income (expenses) -31.25%-42K-11.54%-29K-60.00%-24K-176.74%-119K-453.85%-46K13.51%-32K-136.36%-26K-87.50%-15K-4.88%-43K165.00%13K
Income before tax 3.57%-33.92M-289.86%-34.45M144.03%13.79M-642.29%-103.18M-67.41%-27.84M-146.58%-35.18M76.78%-8.84M9.79%-31.33M87.20%-13.9M42.06%-16.63M
Income tax 102.98%485K-89.52%326K-82.61%629K-161.95%-9.38M-98.74%190K-30,283.33%-16.3M9,324.24%3.11M11,200.00%3.62M1,002.68%15.15M3,747.57%15.03M
Net income -82.24%-34.41M-191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M
Net income continuous Operations -82.24%-34.41M-191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M
Minority interest income
Net income attributable to the parent company -82.24%-34.41M-191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -82.24%-34.41M-191.09%-34.77M137.67%13.16M-222.91%-93.8M11.46%-28.03M-125.02%-18.88M68.64%-11.95M-0.53%-34.94M72.83%-29.05M-11.91%-31.66M
Basic earnings per share -80.00%-0.81-192.86%-0.82137.35%0.31-223.19%-2.2310.67%-0.67-125.00%-0.4569.23%-0.280.00%-0.8375.62%-0.69-7.14%-0.75
Diluted earnings per share -80.00%-0.81-192.86%-0.82136.14%0.3-223.19%-2.2310.67%-0.67-126.32%-0.4569.23%-0.280.00%-0.8375.62%-0.69-7.14%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.85%